[NEU] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
31-Dec-2013
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -161.03%
YoY- -161.03%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 2,988 61 1,506 2,047 0 0 0 -
PBT -3,773 -8,409 -3,645 -7,381 -2,834 -1,298 -1,185 21.26%
Tax 863 360 -4 -5 -9 -24 2 174.63%
NP -4,636 -8,049 -3,641 -7,374 -2,825 -1,273 -1,187 25.46%
Tax Rate - - - - - - - -
Total Cost 7,624 8,110 5,147 9,421 2,825 1,273 1,187 36.30%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -155.15 -13,195.08 -241.77 -360.23 0.00 0.00 0.00 -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -0.06 -0.09 -0.05 -0.11 -0.04 -0.02 -0.03 12.23%
EPS Diluted -0.06 -0.09 -0.05 -0.11 -0.04 -0.02 -0.03 12.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.